Introduction ▼
A wide aneurysm neck (i. e., 4 mm or more) turned out to be the major limitation for the endovascular coil treatment of intracranial aneurysms [1] . The creation of an artifi cial border between the parent artery and the aneurysm orifi ce by deployment of a balloon-expandable coronary stent was the initial solution [2] . However, the insuffi cient fl exibility of balloon-mounted stents and the risk of parent vessel and / or aneurysm injury prevented the general acceptance of the method. The Cerebrence (Medtronic) is a balloon-mounted coronary stent derivative, approved for the treatment of intracranial aneurysms in the EU, but which was fi nally withdrawn from the market [3] . In 2001, the Neuroform (Smart Therapeutics, acquired by Boston Scientifi c) was the fi rst self-expanding microstent to be developed and approved to assist the coil occlusion of wide-necked intracranial aneurysms [4] . In 2008, a modifi cation of this stent was launched as Wingspan (Boston Scientifi c) with an improved delivery system and an increased
Krischek Ö et al. A Comparison of Functional and Physical Properties … Minim Invas Neurosurg 2011; 54: 21 -28 intracranial atherosclerotic stenoses is currently limited to Wingspan. Thrombectomy for acute ischemic stroke with Solitaire was anticipated early in the product history and is proving to be very eff ective [6] . The physical features, the dimensions, and the functional characteristics of these implants show major diff erences. We assume that physicians follow personal preferences and are guided by their clinical experience in the decision-making for which stent they will use in an individual case. Although some aspects of stent design have been reported in the literature, many stent features and their eff ect on functional properties are not well understood. We sought to determine and compare the most relevant properties of the currently available intracranial selfexpanding stents. Knowledge of these features may help physicians in selecting the most appropriate stent for a given vascular anatomy and clinical purpose and enable them to anticipate its behavior and potential issues. Despite the affi liation of one senior author to ev3 (SS), we tried our best to be as neutral and balanced in the description and interpretation of our observations as possible. We do not feel that any of the examined stents is " the best " but rather think that for a given anatomy or purpose, one stent may be better suited than others.
Material and Methods ▼
The intracranial aneurysm neck bridging stents Neuroform3 (Boston Scientifi c), Solitaire (ev3), Leo + (Balt) and Enterprise (Codman Neurovascular) and in addition the stenosis-stent Wingspan (Boston Scientifi c) were analyzed for various functional and structural attributes. For this purpose, 1 -10 units of each stent were used with varying frequencies, as listed in each test. For visual comparison, images with identical magnifi cation factors (10 × and 40 × ) were taken. Offi cial indications and available dimensions were listed. The radial force (often termed as " outward radial force " or " radial strength " ) of a stent corresponds to the force that the stents exerts on the vessel wall and that is available to support the coils inside an aneurysm. There are several methods to measure the radial force of stents. They include the " Iris Test " , the " V-Block Test " , the " Flat Plate Test " , the " Thin Film Test " and the " Pressure Chamber Test " . We collected data using the " Flat Plate Test " , which is the most commonly used method and allows us to measure radial force of all stents regardless of their design. The " Flat Plate Test " places the stent between 2 fl at plates and the radial force of the stent is measured during compression of the 2 plates. In this study, radial force data were collected while the stent diameter was being expanded at 50 % of the labeled diameter of the stent, which corresponds to what is sometimes termed as the chronic outward force [11] . We also collected data using the " Thin Film Test " , which can compress the stent circumferentially through 360 degrees and can mea sure changes in diameter vs. force for both expansion and contraction. In this study, radial force data were collected for chronic outward force. When a stent is delivered to the target site through the microcatheter and deployed, the device will self-expand to a larger diameter by the elastic energy stored in the stent structure until equilibrium is reached between the stored elastic energy and the opposing force from the surrounding vessel. The stored elastic energy in the stent structure produces an outward force known as chronic outward force against the vessel wall. The chronic outward force (also termed as outward radial force) data were collected while expanding the vessel diameter at about 85 % of the labeled vessel diameter. The wall apposition describes a stent ' s ability to remain in close contact with the adjacent vessel wall when deployed in a curved vessel. Stents were deployed in 3 mm tubes having a 3.9 mm centerline radius and in 4 mm tubes with a 4.4 mm centerline radius. Images were captured to visually observe the apposition of each stent with the vessel wall in the curved segment.
Conformability describes a stent ' s ability to adopt the tortuous path of a vessel, instead of forcing the vessel to straighten. In this study, it was measured by quantifying bending stiff ness . Bending stiff ness for each stent was determined by measuring the force exerted by a stent when bent around a 12.5 mm block using mechanical testing equipment manufactured by MTS Systems Corporation. That force was multiplied by the length to obtain the bending moment . Gator backing describes a stent ' s tendency to fl air its struts outward, forming protrusions, when the stent is placed around a bend. The appearance of gator-backing resembles the scales on the back of an alligator. Excessive gator backing may result in poor prevention of coil herniation. To visualize gator backing, stents were deployed within a 3 mm silicone tube with a 12.5 mm radius curve and visually evaluated for the extend of gator backing across the " aneurysm neck " . Kinking is the buckling of a stent when it is bent over a curve. Kinking can result in vessel occlusion. It was measured by deploying stents within 3 mm silicone tubes with a 12.5 mm radius curve and visually evaluate the extent of kinking.
Ovalization describes the phenomenon of the stent lumen fl attening when it is curved ( • ▶ Fig. 1 ). This may result in fl attening of the vessel lumen and ultimately vessel occlusion. Ovalization was tested by deploying the stent into a thin-walled silicone tube and bending the vessel into a 10 mm radius arc. Measured were the minor and major axis lengths of the stent ' s cross-section. Calculated was the eccentricity to quantify ovalization: The ability of a neck bridging stent to hold coils inside an aneurysm and the interaction between stent and parent vessel can be measured as the vessel wall coverage . Vessel wall coverage was calculated by deploying stents in mock vessels of indicated diameters and measuring the uncovered surface area using a microscope and software program. The cell size fi nally determines the diffi culty or ease to catheterize an aneurysm once its orifi ce is bridged by a stent. The stability of coil retention in an aneurysm is also a function of cell size. Cell sizes of the compared stents were measured under the microscope. The method of delivery determines the required eff ort to deploy a stent into the target vessel. The various delivery methods were analyzed from the perspective of clinical functionality.
Results ▼
Magnifi ed views of the structures of the 4 stents further examined may help to understand their features and are shown in • ▶ Fig. 2 . Indications and available sizes are listed in • ▶ Table 1 .
• ▶ Fig. 3 shows a comparison of the radial force as measured by the " Flat Plate Test " , of the 4 aneurysm stents and in addition of the Wingspan stent. Given is the radial force at 50 % compression in the " Flat Plate Test " , with average, maximum and minimum values displayed. There is a clear rank starting with Leo + as the stent with the lowest radial strength, followed by Neuroform3, Enterprise, Solitaire and Wingspan. It may be emphasized that the Wingspan stent has about the 3-fold radial strength of the Leo + stent. 5 measurements were conducted on each stent and varying sample sizes were used for each stent (Leo + = 2, Enterprise = 4, Neuroform = 3, Wingspan = 2, Solitaire = 10).
• ▶ Fig. 4 shows a comparison of the chronic outward force (outward radial force) , as measured by the " Thin Film Test " , of the 4 aneurysm stents and in addition of the Wingspan stent. There is a clear rank starting with Leo + as the stent with the lowest radial force followed by Enterprise, Solitaire, Neuroform 3 and Wingspan. One measurement per stent was conducted using 5 test cycles for each stent (Leo + = 1, Enterprise = 1, Neuroform3 = 2, Wingspan = 2, Solitaire = 30). It is clear that Leo + has the lowest radial force and Wingspan has the highest radial force among all stents tested independent of the test method. Relative ranks of Neuroform3 and Solitaire changes are based on the test method.
At higher oversizing, Solitaire shows higher radial force and at lower oversizing Neuroform 3 shows higher radial force. This is attributed to their specifi c design features. At lower oversizing, an unrolling mechanism may be operative in Solitaire due to a longitudinal split in its design thereby showing lower radial force. Additionally, the closed cell designs tend to exhibit a higher radial force at higher oversizing. The wall apposition was evaluated in 3 mm tubes having a 3.9 mm radius ( • ▶ Fig. 5a ) and in 4 mm tubes with a 4.4 mm radius ( • ▶ Fig. 5b ). Neuroform3, due to the open cell design, maintains good wall apposition even in tortuous paths. The wall apposition of the Solitaire stent is similar to that of the Neuroform but better than that of the Enterprise. The wall apposition
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Discussion ▼
This work should be a fi rst step towards a comprehensive " physician ' s guide " for intracranial stents, as they are available for coronary [12] and carotid stents [13] .
The features of the 5 intracranial stents examined in this study are very diff erent. Some of the above-described observations correspond well with other in vitro studies and with clinical experience. The assessment of each stent has to consider various aspects. How well does a stent meet the primary requirements (i. e., retain coils in a wide necked aneurysm)? What eff ects have to be expected in this context (e. g., vessel straightening, difficulty in catheterizing an aneurysm through stent struts)? How about secondary eff ects such as hemodynamic infl uence on the aneurysm? Can adverse eff ects (e. g., intimal hyperplasia with in-stent stenosis) be expected or anticipated from certain stent features?
The Neuroform was the fi rst self-expanding intracranial stent and became available in a clinical trial in Europe in 2001 [4] .
Since then, a large number of publications have focused on various aspects of this device. The basic structure of the Neuroform is a sequence of sinusoidal crown segments of 2.5 mm length. Adjacent crowns have 2 or 3 connecting points. The stent cannot be repositioned after the fi rst crown has been deployed. Stent placement in general was an issue with the fi rst Neuroform gen- eration, and was overcome with Neuroform2 and following device variants. The guidewire within the 3F stent-catheter running coaxially through the mounted stent, however, remains a potential source of complications due to distal wire injury [14] .
The structure of the Neuroform stent is unstable and catheterization of the aneurysm immediately after stent deployment may result in stent displacement. Staged procedures with an interval of 6 -8 weeks between stenting and coiling are therefore recommended for unruptured aneurysms [15, 16] . Within the fi rst months after stent deployment, complete endothelialization can be expected, unless there is a large gap between stent and the intimal surface [17] . Due to the limited radial force of the Neuroform stent, small vessels with a diameter of less than 2 mm are well suitable for Neuroform stent placement [18] . The hemodynamic eff ect of a single Neuroform stent on a bridged aneurysm was found to be insignifi cant in computational hemodynamic simulations [19] . Telescoping of Neuroform stents instead can sometimes induce fl ow diversion [15, 20, 21] . In vitro examinations (e. g., ultra-high resolution MicroCT studies) have shown that Neuroform stent deployment may be associated with a variety of adverse phenomena such as focal intercrown separation on the convex side of a vessel curve, penetration of crowns on the concave side, strut vertex misalignment, strut prolapse into the lumen, crown protrusion into large side vessel and aneu-rysm orifi ce, wall prolapse into the lumen at the cell center, undulations of the vessel wall, strut and marker embedding into the vessel wall and formation of creases at the strut vertices [22 -25] . Vessel straightening by Neuroform was described but is of limited importance in clinical practice [25] . All eff ects related to the open cells of the Neuroform stent are not possible with the competing closed cell stents of this study. Undulations of the vessel walls are sometimes obvious on angiograms after oversized deployment of a Neuroform or Solitaire stent. Fibrocellular in-growth within the stented vessel segment promotes increased durability of coil-occlusion and may be more pronounced in an open-cell design stent [26] . In-stent stenosis due to neointimal hyperplasia occurs in about 5 -6 % of patients after Neuroform implantation for aneurysm treatment [27] . Clinically insignifi cant in-stent stenosis is even more frequent [28] . The rate of in-stent stenosis recurrence after conventional balloon dilatation is high and an accentuation of the intimal hyperplasia adjacent to the stent markers is sometimes evident [29] . In our experience, in-stent stenosis after stent-assisted coiling of aneurysms is generally rare but seems to be increased in patients with underlying vasculitis. Bifurcation reconstruction can be achieved with both " crossing " and " kissing " using Neuroform stents [30, 31] . The Wingspan stent was originally developed for the endovascular treatment of intracranial atherosclerotic stenoses [5] . It is actually a design variant of the Neuroform stent with an optimized delivery system and an increased radial force. Some physicians have reported good results with this stent for aneurysm indications [32] . The increased radial force, which is the main diff erentiating feature of the Wingspan stent from the Neuroform stent, may add some stability for aneurysm coiling. The high in-stent restenosis rate (e. g., 88 % for supraclinoid stenoses in patients aged 55 years younger) [33] might also be related to the high radial force of the Wingspan stent. The hemodynamic eff ects of Neuroform and Wingspan are expected to be more or less equivalent but computational fl uid dynamics analysis found more infl uence on intra-aneurysmal blood fl ow for the Wingspan stent [34] .
Solitaire was the fi rst fully retrievable and detachable intracranial stent [6] . The stent is more stable than Neuroform3 and less thrombogenic than Leo( + ) in our clinical experience. Due to the large cell size, catheterization of the aneurysm sac after stent deployment is well controllable and may be easier than with the competitors [35] . In our opinion, the Solitaire stent is less prone to microcatheter-induced deformation or displacement, which may happen with Neuroform and Enterprise, respectively. We observed that the retrievability of the stent after full deployment allows accurate fi nal positioning as well as temporary stenting similar to balloon remodeling though without blood fl ow interruption ( " stent remodeling " ). Controlled detachment can be used to stabilize the stent position during catheterization, coil delivery, or deployment of a second stent. In some clinical situations, there may be an advantage to a stent having a separate guide wire. A central wire running through the lumen of the mounted stent is part of the Neuroform3 and of the Enterprise stent system but is missing at the Solitaire. Such a wire facilitates recatheterization of a stent once deployed but also carries the risk of distal vessel injury. As observed by other sites, the thrombogenicity of the Solitaire stent is low and allows deployment with heparinization and ASA induced antiaggregation only, without the administration of clopidogrel [35] . This is a major advantage in the treatment of patients with recently ruptured aneurysms. The use of heparinization and ASA-induced antiaggregation only is also valid for Enterprise and Neuroform3 stents. An intrinsic hemodynamic eff ect of the Solitaire is apparently non-existing, mainly due to the large cell size. Endothelialization can be expected as with every intracranial stent but we are not aware of any case of in-stent stenosis after Solitaireassisted aneurysm coiling. Solitaire is currently not indicated for atherosclerotic stenoses and the in-stent restenosis rate associated with its application in atherosclerotic disease is unknown.
Reconstructing vessel bifurcations by crossing stent-in-stent deployment (Y-confi guration) is possible with the Solitaire [35] .
Leo and Leo + are braided stents, which can be repositioned after partial deployment [36] . Diff erent than laser-cut stents, the Leo( + ) ' s cells are closed but not predetermined in size and shape. The cells increase in size at the convexity and decrease in size at the concavity. The Leo stent has a braiding angle of 45 ° , which is increased to 60 ° for the Leo + . In addition the Leo + comes with fl aired proximal and distal ends and with a 30 % increase of radial force [37] . Some authors state a higher radial force for the Leo( + ) than the Neuroform3 and the Enterprise stents [38] , which is wrong. The original Leo version was known for thromboembolic complications [38] . This issue was overcome with subsequent device modifi cations, which may be related to the observation that the revised stent (Leo + ) does in vitro show neither midsection fl attening nor the inward crimping of the proximal and distal ends [37] . The eff ective cell size of the Leo( + ) stent is infl uenced by the diameter of the target vessel. Oversizing of the stent (i. e., the stent is unable to fully expand) will result in larger cell sizes. Larger cells are easier accessible for a microcatheter but have less hemodynamic eff ect on the aneurysm ' s in-and outfl ows. Among the stents examined, Leo( + ) has in general the most distinct hemodynamic eff ect, which may purposely be applied for fl ow diversion [38] . A major drawback of the Leo( + ) stent-line is the appendent Vasco microcatheter, which is diffi cult to navigate in tortuous vessels [37] . The Leo( + ) stent does not allow either " crossing " or " kissing " deployment and is therefore not suitable for bifurcation reconstruction.
The Enterprise stent is retractable after partial deployment. Exact placement is mostly easy but penetration of the small stent cells with a microcatheter can be challenging [8, 9, 39] . The body of the stent itself is almost invisible under fl uoroscopy [8] . Only proximal and distal tantalum markers allow the identifi cation of the stent position. The ability of the Enterprise stent to retain coils in an aneurysm is excellent. In curves, the cell remains stable but kinking and fl attening of the Enterprise body can occur [24] . We used telescoping Enterprise stents several times for attempted fl ow diversion with poor results, indicating a limited hemodynamic eff ect. The Enterprise stent is available with a nominal diameter of 4.5 mm, and is indicated for vessel diameters ranging from 2.5 mm to 4 mm. In-stent stenosis was rarely observed by us after aneurysm treatment. The stent is coated with Parylene C and has therefore a very smooth surface. Stent displacement may be encountered if coiling is attempted immediately after deployment. Therefore awaiting stent endothelialization or coiling with a " jailed " microcatheter is recommended [9] . An adverse event unique for the Enterprise is secondary proximal migration if a short stent is deployed into vessel segments with large caliber diff erences [40] . We observed Enterprise in-stent stenosis due to intimal hyperplasia after stenosis treatment with a frequency of about 25 % . Focal intimal hyperplasia is sometimes observed at the stent markers. Poor attachment of the end-markers to the vessel surface has been observed for both Neuroform and Enterprise and may induce low wall shear stress as a reason of intimal hyperplasia [25, 41] . Similar eff ects are to be expected for Solitaire. Both " crossing " and " kissing " deployment for bifurcation reconstruction is possible with the Enterprise stent. Due to the small cell size, " crossing " 2 Enterprise stents, however, can be quite diffi cult. We therefore prefer the combination of a Solitaire with an Enterprise stent for this purpose, deploying the Solitaire stent fi rst into the vessel with the steeper angle. Temporary stent deployment ( " stent remodeling " in analogy to balloon remodeling) has successfully been applied with a partially deployed Enterprise stent [42] .
There is no comparative study on the safety and effi cacy of different self-expanding intracranial aneurysm stents available and in fact such a study would be diffi cult to justify. In general, Enterprise and Solitaire are certainly more convenient to use than the Neuroform system [39] . Both stents can be deployed through 0.021 " ID microcatheters, which can also be used for coil insertion. The Leo + is a good choice whenever an enhanced hemodynamic eff ect is required. Some physicians use the Leo + or Enterprise stent to prepare a target vessel for subsequent fl ow diverter deployment. Flow diversion by multiple telescoping stents of the same kind has been demonstrated [12, 15] . The efficacy of combinations of stents with various designs (e. g., Enterprise or Neuroform with Solitaire) is unknown.
Conclusion ▼
In 2010 fi ve self-expanding intracranial stents were available. They have basically diff erent physical features and clinical functions. None of these stents is ideal in the sense of universally meeting all possible requirements. Knowledge of the stent features, procedural experience and proper technical skills are mandatory for safe and successful endovascular treatment on the basis of individualized decision making. The medical device industry is asked to address the above shown issues. Systematic variations of existing stent designs and new developments are Fig. 10 a and b : Vessel wall coverage for various stents. The graphs show that the Solitaire stent has the lowest and the Leo + stent has the highest percentage in both 3 mm simulated vessels and 4 mm simulated vessels.
required to further improve the results of intracranial stenting, way beyond aneurysm treatment. Directions of development should include non-thrombogenic stents deployable without anti-aggregation and methods for mid-and long-term temporary stenting (e. g., bioresorbable stents). Aneurysm stents are only the initial ignition for a device family that will improve the treatment of intracranial stenoses, dissections and acute stroke.
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